ギンクゴリドB

ギンクゴリドB 化学構造式
15291-77-7
CAS番号.
15291-77-7
化学名:
ギンクゴリドB
别名:
ギンクゴリドB;ギンコライドB;ギンコリドB;ギンコリドB GINKGO BILOBA(イチョウ)葉由来;(1R,3R,6R,7S,8S,10R,11R,12S,13S,16S,17R)-8-tert-ブチル-6,12,17-トリヒドロキシ-16-メチル-2,4,14,19-テトラオキサヘキサシクロ[8.7.2.01,11.03,7.07,11.013,17]ノナデカン-5,15,18-トリオン;1α-ヒドロキシギンクゴリドA;(1R,3aS,6aα,7aR,10aα,11aR)-2,3,8,10a,11-ペンタヒドロ-3β-(1,1-ジメチルエチル)-4β,7bα,11β-トリヒドロキシ-8α-メチル-9H-1α,7aα-(エポキシメタノ)-1H-シクロペンタ[c]フロ[2,3-b]フロ[3′,2′:3,4]シクロペンタ[1,2-d]フラン-5,9,12(4H)-トリオン;ギンゴライドB
英語名:
Ginkgolide B
英語别名:
BN 52021;BGinkgolid;GINKGOLIDE B;GINKGOLIDE B(SH);7-DEOXYGINKGOLIDE C;GINKOLIDE B;BN 52021;Ginkgolide B (BN-52021);GinkgolideA,1-hydroxy-, (1β)-;ginkgolide B from ginkgo leaves;Ginkgolide B, froM Ginkgo biloba
CBNumber:
CB3745566
化学式:
C20H24O10
分子量:
424.4
MOL File:
15291-77-7.mol
MSDS File:
SDS

ギンクゴリドB 物理性質

融点 :
280°C (dec.)
比旋光度 :
D24 -52.6° (c = 1 in ethanol)
沸点 :
762.4±60.0 °C(Predicted)
比重(密度) :
1?+-.0.1 g/cm3(Predicted)
貯蔵温度 :
Sealed in dry,Store in freezer, under -20°C
溶解性:
DMSO (最大 40mg/ml) またはエタノール (最大 10mg/ml) に可溶。
酸解離定数(Pka):
pKa1 7.14; pKa2 8.60; pKa3 11.89(at 25℃)
色:
白い
水溶解度 :
DMSOに可溶。水およびエタノールにわずかに溶ける
BRN :
4727611
安定性::
購入日から2年間安定です。この DMSO またはエタノール溶液は、-20°C で 3 か月間保存できます。
InChIKey:
SQOJOAFXDQDRGF-MMQTXUMRSA-N
SMILES:
[C@@]12(O)[C@]34C(=O)O[C@@H]5C[C@@H](C(C)(C)C)C6([C@@H](O)C(=O)O[C@@]6([H])O3)C45[C@H](O)[C@]1([H])OC(=O)[C@H]2C
LogP:
2.070 (est)
CAS データベース:
15291-77-7(CAS DataBase Reference)
安全性情報
  • リスクと安全性に関する声明
  • 危険有害性情報のコード(GHS)
Sフレーズ  24/25
WGK Germany  3
10-21
HSコード  29322090
絵表示(GHS) GHS hazard pictograms
注意喚起語
危険有害性情報
コード 危険有害性情報 危険有害性クラス 区分 注意喚起語 シンボル P コード
H315 皮膚刺激 皮膚腐食性/刺激性 2 警告 GHS hazard pictograms P264, P280, P302+P352, P321,P332+P313, P362
H319 強い眼刺激 眼に対する重篤な損傷性/眼刺激 性 2A 警告 GHS hazard pictograms P264, P280, P305+P351+P338,P337+P313P
H335 呼吸器への刺激のおそれ 特定標的臓器毒性、単回暴露; 気道刺激性 3 警告 GHS hazard pictograms
注意書き
P264 取扱い後は皮膚をよく洗うこと。
P264 取扱い後は手や顔をよく洗うこと。
P280 保護手袋/保護衣/保護眼鏡/保護面を着用するこ と。
P302+P352 皮膚に付着した場合:多量の水と石鹸で洗うこと。
P305+P351+P338 眼に入った場合:水で数分間注意深く洗うこと。次にコ ンタクトレンズを着用していて容易に外せる場合は外す こと。その後も洗浄を続けること。
P321 特別な処置が必要である(このラベルの... を見よ)。
P332+P313 皮膚刺激が生じた場合:医師の診断/手当てを受けるこ と。
P362 汚染された衣類を脱ぎ、再使用す場合には洗濯をすること。

ギンクゴリドB 価格 もっと(30)

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入
富士フイルム和光純薬株式会社(wako) W01CHDASB-00007181 ギンコリドB
GINKGOLIDE B
15291-77-7 10mg ¥96800 2024-03-01 購入
富士フイルム和光純薬株式会社(wako) W01CHDASB-00007181 ギンコリドB
GINKGOLIDE B
15291-77-7 25mg ¥190400 2024-03-01 購入
関東化学株式会社(KANTO) 49063-63 ギンクゴリドB
Ginkgolide B
15291-77-7 10mg ¥43000 2024-03-01 購入
Sigma-Aldrich Japan PHL89205 ギンコリドB phyproof? Reference Substance
phyproof? Reference Substance
15291-77-7 10MG ¥38420 2024-03-01 購入
Sigma-Aldrich Japan G6910 ギンコリドB Ginkgo biloba(イチョウ)葉由来 ≥90% (HPLC)
Ginkgolide B from Ginkgo biloba leaves ≥90% (HPLC)
15291-77-7 10mg ¥25100 2024-03-01 購入

ギンクゴリドB 化学特性,用途語,生産方法

外観

白色~ほとんど白色粉末~結晶

説明

Ginkgo biloba is a perennial tree belonging to Ginkgoaceae (Ginkgo biloba L., Yin Xing). Its seeds, also known as ginkgo, have a long history of application in traditional medicine for its medicinal value. With promoting blood circulation by removing blood stasis, Ginkgo biloba has a long history of its application in traditional Chinese medicine
In recent years, it has been widely used in the treatment of cerebral ischemic diseases. After further study, it was found that the effective component is ginkgolide compound, which laid the foundation for the development of small molecule drugs.

化学的特性

White Crystalline Solid

物理的性質

Appearance: ginkgolide B is a white powder. Solubility: weighed 0.98?g and dissolves in 1L water (calculation). Melting point: the compound melts at 280? °C (calculation)

来歴

The leaf of Ginkgo biloba is sweet, bitter, astringent, and mild. With activating blood circulation to remove blood stasis, dredging collaterals, relieving pain, and asthma, it is applied for treating blood stasis, chest pain, stroke, lung deficiency cough, and hyperlipidemia.
As early as in the 1930s, scientists began to study ginkgo and harvest a variety of ginkgolide . Ginkgolide B was isolated and its structure illustrated by Wan Shan et?al. in 1967. Subsequently, it was synthesized by Corey et?al. in 1988. The preparation of effective components of Ginkgo biloba has been listed at home and abroad with development.
The Ginkgo biloba extract consisting of ticlopidine is widely used in overseas market for the treatment of cerebral infarction. Intravenous injection of ginkgolide B is applied for the treatment of inflammation, but the project has been in the state, and there is no progress in it for many years. In addition, whether other extract of Ginkgo biloba can be used for the treatment of stable angina, cognitive impairment is still in preclinical research status.

使用

Ginkgolide B is used as a potent PAF-R antagonist. Ginkgolide B speeds up PAF hydrolysis by promoting PAF-AH I α2 homodimer activity. Additionally, this compound has been reported to inhibit neutrophil degranulation in vitro. Inhibits superoxide production in vitro and inhibits bronchoconstriction and is neuroprotective following oral administration in vivo.

適応症

The injection consists of multiple components, and there are three kinds of substance mainly in diterpene ginkgolides meglumine injection. It promotes blood circulation by removing blood stasis and activates the channels and collaterals for cerebral ischemia treatment.

生物活性

Platelet-activating factor (PAF) receptor antagonist (K i = 1.3 μ M). Inhibits neutrophil degranulation and superoxide production in vitro and inhibits bronchoconstriction and is neuroprotective following oral administration in vivo .

薬理学

Ginkgolide B has a variety of pharmacological effects, mainly in cardiovascular and cerebrovascular protection and neuroprotection. On the one hand, with the strongest activity in nature, the platelet-activating factor (PAF) receptor antagonist is recognized by the public . PAF can inhibit the downstream inflammatory cascade for anti-inflammatory. It also can alleviate cerebral infraction volume and cerebral edema induced by cerebral ischemia among the animal model of cerebral ischemia reperfusion through unknown mechanism. By inhibiting NF-κB and TNF-α, the apoptosis of nerve cell can be alleviated. The compound protects the abdominal cavity and intestinal tract by inhibiting release of neutrophil chemotactic protein by macrophage.

臨床応用

Oral and injection preparations are applied widely in clinical therapy. Made in oral preparation, flavonoids are the main component of raw material. There are little chemical compounds in injection, and ginkgolides are the main component whose content is different from each other. Listed ginkgolide injection is applied for ischemia stroke formed by blood stasis with promoting blood circulation by removing blood stasis and clearing and activating the channels and collaterals. Compared with Shuxuening injection in clinical trials, ginkgolides injection is consistent in improving indicators effect, such as protection in nerve injury and others.

ギンクゴリドB 上流と下流の製品情報

原材料

準備製品


ギンクゴリドB 生産企業

Global( 325)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
Shaanxi Cuikang Pharmaceutical Technology Co., Ltd
+8618829768577
gao490372054@gamil.com China 1250 58
Shaanxi Cuikang Pharmaceutical Technology Co., Ltd
+86-19164747840 +86-13119157289
13119157289@163.com China 2971 58
Shaanxi Haibo Biotechnology Co., Ltd
+undefined18602966907
qinhe02@xaltbio.com China 1000 58
Shanghai Zheyan Biotech Co., Ltd.
18017610038
zheyansh@163.com CHINA 3620 58
career henan chemical co
+86-0371-86658258
sales@coreychem.com China 29914 58
Chengdu Biopurify Phytochemicals Ltd.
+8618080483897
sales@biopurify.com China 3424 58
Nanjing Dolon Biotechnology Co.,Ltd.
18905173768
sales@dolonchem.com CHINA 2972 58
Hubei xin bonus chemical co. LTD
86-13657291602
linda@hubeijusheng.com CHINA 22968 58
BOC Sciences
+1-631-485-4226
inquiry@bocsci.com United States 19553 58
Chongqing Chemdad Co., Ltd
+86-023-61398051 +8613650506873
sales@chemdad.com China 39916 58

ギンクゴリドB  スペクトルデータ(MS)


15291-77-7(ギンクゴリドB)キーワード:


  • 15291-77-7
  • 7-DEOXYGINKGOLIDE C
  • BN 52021
  • GINKGOLIDE B
  • ginkgolide B from ginkgo leaves
  • (1R,3S,3aS,4R,6aR,7aR,7bR,8S,10aS,11R,11aR)-3-(1,1-Dimethylethyl)hexahydro-4,7b,11-trihydroxy-8-methyl-9H-1,7a-(epoxymethano)-1H,6aH-cyclopenta[c]furo[2,3-b]furo[3',2':3,4]cyclopenta[1,2-d]furan-5,9,12(4H)-trione
  • ginkgolide b from ginkgo biloba leaves
  • GinkgolideA,1-hydroxy-, (1β)-
  • Ginkgolide B, froM Ginkgo biloba
  • BGinkgolid
  • GINKGOLIDE B(SH)
  • Ginkgolide B, 98%, from Ginkgo biloba L.
  • GINKOLIDE B;BN 52021
  • Ginkgolide B (BN-52021)
  • (1R,3S,3aS,4R,6aR,7aR,7bR,8S,10aS,11R,11aR)-3-(1,1-Dimethylethyl)hexahydro-4,7b,11-trihydroxy-8-methyl-9H-1,7a-(epoxymethano)-1H,6aH-cyclopenta[c]furo[2,3-b]furo[3',2':3,4]cyclopenta[1,2-d]furan-5,9,12(4H)-trione
  • ギンクゴリドB
  • ギンコライドB
  • ギンコリドB
  • ギンコリドB GINKGO BILOBA(イチョウ)葉由来
  • (1R,3R,6R,7S,8S,10R,11R,12S,13S,16S,17R)-8-tert-ブチル-6,12,17-トリヒドロキシ-16-メチル-2,4,14,19-テトラオキサヘキサシクロ[8.7.2.01,11.03,7.07,11.013,17]ノナデカン-5,15,18-トリオン
  • 1α-ヒドロキシギンクゴリドA
  • (1R,3aS,6aα,7aR,10aα,11aR)-2,3,8,10a,11-ペンタヒドロ-3β-(1,1-ジメチルエチル)-4β,7bα,11β-トリヒドロキシ-8α-メチル-9H-1α,7aα-(エポキシメタノ)-1H-シクロペンタ[c]フロ[2,3-b]フロ[3′,2′:3,4]シクロペンタ[1,2-d]フラン-5,9,12(4H)-トリオン
  • ギンゴライドB
Copyright 2017 © ChemicalBook. All rights reserved